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ChronnectomeA B S T R A C T
Frontotemporal Dementia (FTD) is preceded by a long period of subtle brain changes, occurring in the absence of
overt cognitive symptoms, that need to be still fully characterized. Dynamic network analysis based on resting-
state magnetic resonance imaging (rs-fMRI) is a potentially powerful tool for the study of preclinical FTD.
In the present study, we employed a "chronnectome" approach (recurring, time-varying patterns of connec-
tivity) to evaluate measures of dynamic connectivity in 472 at-risk FTD subjects from the Genetic Frontotemporal
dementia research Initiative (GENFI) cohort.
We considered 249 subjects with FTD-related pathogenetic mutations and 223 mutation non-carriers (HC).
Dynamic connectivity was evaluated using independent component analysis and sliding-time window correlation
to rs-fMRI data, and meta-state measures of global brain flexibility were extracted.
Results show that presymptomatic FTD exhibits diminished dynamic fluidity, visiting less meta-states, shifting
less often across them, and travelling through a narrowed meta-state distance, as compared to HC. Dynamic
connectivity changes characterize preclinical FTD, arguing for the desynchronization of the inner fluctuations of
the brain. These changes antedate clinical symptoms, and might represent an early signature of FTD to be used as
a biomarker in clinical trials.1. Introduction
Resting state functional magnetic resonance imaging (rs-fMRI) has
become a useful tool to investigate the connectivity changes in neuro-
degenerative dementias (Pievani et al., 2014a; Premi et al., 2014b).
Spontaneous brain activity at rest is organized in functionally specialized
large-scale networks, that roughly correspond to different functional
domains and that are selectively damaged by various neurodegenerative
conditions (de Pasquale et al., 2017).
However, previous results make the implicit assumption that the
functional coupling among brain regions is static and unchanging over
short periods of time (Damoiseaux et al., 2006; De Luca et al., 2006; Liu
et al., 2018).
This concept has since been modified with analytic approaches that
capture the fact that the human brain is an interacting dynamic network
and its architecture of coupling among brain regions varies across time
(termed “the chronnectome”) (Calhoun et al., 2014; Canolty et al., 2010;
Chang and Glover, 2010; Fries, 2005; Hillebrand et al., 2016; Sakoglu
et al., 2010). Dynamic connectivity studies have demonstrated reoccur-
ring patterns of brain functional connectivity, or functional connectivity
“states”, that are reproducible over time and across subjects (Allen et al.,
2014; Chang and Glover, 2010; Marusak et al., 2017). Initial dynamic
connectivity studies were based on the assumption that subjects were
allowed to be in only one “state” at a given point in time, while recent
work has introduced the concept of “meta-states”, suggesting that sub-
jects may be in multiple states to varying degrees at the same point in
time (Calhoun et al., 2014; Miller et al., 2016). Thus, for instance, if in the
time-course we are able to identify six distinct states of functional dy-
namic connectivity, at a given point in time each subject will have a
weighted probability to be in more than one state (Miller et al., 2016).
Meaningful measures of meta-state dynamic fluidity, such as the number
of meta-states a subject passes through or the number of switches from
one meta-state to another, have been suggested as an intuitive way to
characterize global dynamic connectivity behaviour, showing promise
for predicting mental states and cognitive performances (Liu et al., 2018;
Preti et al., 2017). From this point of view, meta-state measures could
provide a more “global” information on the effect of an ongoing neuro-
degenerative process, overcoming the evaluation of single specific brain
areas or connectivity pathways, and evaluating global perturbation of the
brain activity's temporal dynamics (Calhoun et al., 2014; Miller et al.,
2016).
Frontotemporal Dementia (FTD) is a neurodegenerative disease
characterized by behavioural abnormalities, impairment of executive
functions and language deficits (Gorno-Tempini et al., 2011; Rascovsky
et al., 2011) and defined by focal frontotemporal atrophy (Whitwell
et al., 2009). In a significant proportion of the cases, FTD is an inherited646autosomal dominant disorder; mutations in the Granulin (GRN), chro-
mosome 9 open reading frame 72 (C9orf72) orMicrotuble Associated Protein
Tau (MAPT) genes drive up to ~40% of Mendelian cases (Borroni et al.,
2008b). In genetic FTD, the neural substrates associated with the pre-
symptomatic stage need to be fully characterized: although the pertur-
bation of static large-scale networks has already been demonstrated
(Dopper et al., 2014; Lee et al., 2017; Premi et al., 2014a; Whitwell et al.,
2011; Zhou et al., 2010), the specific findings were not fully consistent, in
particular for Salience network. In fact, both an increased connectivity in
medial frontal regions in GRN carriers (Borroni et al., 2008a; Premi et al.,
2014b) (specially within the Salience Network), and a reduced
seed-based connectivity between anterior cingulate cortex and posterior
regions of the Default Mode Network in a group of GRN and MAPT car-
riers were reported (Dopper et al., 2014). Furthermore, a recent study on
presymptomatic C9orf72 carriers showed a reduced functional connec-
tivity in all the studied networks (Salience, Default Mode, Sensorimotor
and medial pulvinar networks) (Lee et al., 2017). Finally, a study on a
small group of MAPT carriers demonstrated an altered functional con-
nectivity in the Default Mode Network with no alteration of Salience
Network (Whitwell et al., 2011). The evaluation of large-scale structural
network topology along with their temporal dynamics might offer a
theoretical framework that can contribute to understand the earliest
abnormalities in FTD, with the new perspective of whole brain assess-
ment (Avena-Koenigsberger et al., 2017). Thus, by a data-driven
approach, we did not study single specific brain pathways, but the
global dynamic perturbation of the brain in the presymptomatic phase of
FTD.
These premises set the stage for the present study, in which we
analyzed dynamic brain connectivity in presymptomatic subjects car-
rying GRN, MAPT or C9orf72mutations with the purpose a) to assess the
chronnectome fingerprint by considering meta-state measures; b) to
study the association between chronnectome changes and cognitive
performances; and c) to correlate chronnectome changes with expected
age at disease onset, to evaluate if meta-state measures are associated
with proximity to clinical onset. To this end, we analyzed rs-fMRI data of
472 subjects from the Genetic Frontotemporal Dementia Initiative
(GENFI) cohort (http://genfi.org.uk) using a dynamic functional network
connectivity (dFNC) approach to investigate the chronnectome in pre-
symptomatic mutations carriers as compared to mutation non-carriers.
2. Methods
2.1. Subjects
Data for this study were drawn from the GENFI multicenter cohort
study, which consists of 23 research centers in Europe and Canada.
Table 1
Demographic characteristics of included participants.
Characteristic Carriers
(n¼ 249)
Non-carriers
(n¼ 223)
P-
valuea
Age (years) 44.7 11.7 47.2 13.2 0.042
Female, % 64.7% 56.5% 0.073^
Education (years) 14.4 3.2 14.1 3.3 0.242
Years at expected onset
(years)
13.8 11.3 – –
Cognitive and behavioural assessment
MMSE 29.2 1.1 29.4 0.9 0.633
CBI-R 4.45 8.2 3.3 6.1 0.098
TMT-A (Z-scores) 2.5 64.5 10.2 70.3 0.075
TMT-B (Z-scores) 8.2 80.7 14.4 69.0 0.345
a Mann-Whitney U test, otherwise specified; C^hi-Square test; results are
expressed as mean standard deviation, otherwise specified. MMSE: Mini-
Mental State Examination; CBI-R: Cambridge Behavioural Inventory Revised
version; TMT-A: part A of the Trial Making Test; TMT-B: part B of the Trial
Making Test.
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et al., 2015). Local ethics committees approved the study at each site and
all participants provided written informed consent according to the
Declaration of Helsinki.
We considered asymptomatic participants at risk to carry GRN,
C9orf72 or MAPT mutations. Between January 2012 and January 2017,
we considered 472 participants, of which 249 were mutation carriers (45
with MAPT, 122 with GRN, and 82 with C9orf72 mutations) and 223
were mutation non-carriers. Subjects were enrolled from 18 centers
belonging to the GENFI network (4 centers were excluded from the
present project for image artifacts, very low number of included subjects
(<2), or for using 1.5T MRI scanner); the MRI parameters for each of the
18 included centers was reported in Supplementary Table 1. De-
mographic characteristics of mutation carriers and mutation non-carriers
are reported in Table 1.
Estimated years from expected symptom onset in presymptomatic
mutation carriers were calculated as the age of the participant at the time
of the study assessment minus themean familial age at symptom onset, as
previously reported (Rohrer et al., 2015).
Included at-risk subjects underwent a careful recording of de-
mographic data and a standardized clinical and neuropsychological
assessment (derived from the Uniform Data Set (Morris et al., 2006)), as
previously published (Premi et al., 2017). We considered tests highly
sensitive to identify initial changes in presymptomatic genetic FTD, as
previously reported (Rohrer et al., 2015). Thus, we considered assess-
ment of behavioural symptoms with the Cambridge Behavioural In-
ventory Revised version (CBI-R) (Wear et al., 2008), general cognitive
function with the Mini-Mental State Examination (MMSE) (Morris et al.,
2006), and cognitive processing speed and executive functions assessed
with the part A and part B of the Trial Making Test (TMT) (Morris et al.,
2006), respectively. For each test, apart from the MMSE and CBI-R, we
calculated Z scores based on language-specific norms (Rohrer et al.,
2015). Neuropsychological evaluation was harmonized across sites.2.2. MRI acquisition
MRI protocol was common to all the GENFI sites, and adapted for
different scanners; no pre-study phantom harmonization was performed
at local level. In summary, T2-weighted echo planar imaging (EPI) se-
quences sensitized to blood oxygenation level dependent (BOLD)
contrast for rs-fMRI were considered in the present study (see Supple-
mentary Table 1 for details on the fMRI protocol used by each site). As
the repetition times (TRs, ranging from 2200ms to 2500ms) and the
volume numbers (ranging from 140 to 200) varied across the GENFI
centers, we considered only the first 140 vol of the EPI images for each647subject (mean acquisition time: 311.5 4.95 s). During scanning, sub-
jects were asked to keep their eyes closed, not to think of anything in
particular, and not to fall asleep.
2.3. Neuroimaging pre-processing and analysis
Functional data were pre-processed using the toolbox for Data Pro-
cessing & Analysis for Brain Imaging (DPABI, http://rfmri.org/dpabi)
(Yan et al., 2016) based on the Statistical Parametric Mapping (SPM12)
software.
For each subject, the first 2 volumes of the fMRI series were dis-
charged to account for magnetization equilibration. The remaining
138 volumes underwent slice-timing correction and were realigned to
the first volume. Any subject who had a maximum displacement in any
direction larger than 2.5 mm, or a maximum rotation (x,y,z) larger
than 2.5, was excluded. We considered absolute (mean translation
and mean rotation) and relative (framewise displacement (FD): Power
(FD-P) (Power et al., 2012), Jenkinson (FD-J) (Jenkinson et al., 2012),
Van Dijk (FD-VD) (Van Dijk et al., 2012)) and DVARS (D for the
temporal derivative of time courses, VARS referring to RMS, root mean
squared head position change) (Power et al., 2012) (see Supplemen-
tary Table 2) motion parameters. Data were subsequently spatially
normalized to the EPI unified segmentation template in Montreal
Neurological Institute coordinates derived from SPM12 software and
resampled to 3 3 3 cubic voxels. We preferred a normalization to
the EPI template (instead of T1-based normalization) in line with
recent data demonstrating that EPI normalization is able to reduce
variability across subjects (especially when EPI distortion correction is
not applied, as in our case) and boost the effective sample size by
15–25%. Furthermore, studies assessing distance maps and intra sub-
ject variability in multicentre cohorts by EPI normalization are com-
parable to our data (Calhoun et al., 2017). Spatial smoothing with an
isotropic Gaussian kernel with full-width at half-maximum (FWHM),
10 mm was applied; this threshold smoothing value was chosen for a
number of reasons: 1) we assessed dFC within large areas, which are
not usually affected by a relative large spatial smoothing; 2) we
adopted Abrol's template to estimate the dFC (Abrol et al., 2017)
(which has been calculated on 7500 healthy subjects), and conse-
quently we opted for similar fMRI pipeline (Abrol et al., 2016) (10 mm
FWHM); 3) spatial smoothing of 8–10mm FWHM is recommended to
increase sensitivity (Mikl et al., 2008).
2.4. Functional networks decomposition
The functional imaging data were processed using the GIFT (GIFT
toolbox, http://mialab.mrn.org/software/gift) (Calhoun et al., 2001)
and a spatially constrained ICA algorithm (Wang et al., 2016) called
Group Information Guided independent component analysis (GIG-ICA)
was used to compute spatial maps that corresponded to those from a
previous analysis (Du et al., 2016). In this approach, brain network
spatial maps are used as reference templates to calculate functional
networks for each individual subject one-by-one by maximizing inde-
pendence in the context of the spatial constraint. These template maps
include the brain networks with a neuronal origin (not artefactual) and
assign the remaining data to be noise. We take advantage from the
recently published set of 37 spatial maps derived from 7500 healthy
subjects as spatial references for our network selection (Abrol et al.,
2017). We then considered only cortical and subcortical networks, and
we discharged cerebellar networks due to incomplete coverage of cere-
bellum in our sample, thus considering 35 spatial maps. The TR of each
subject was entered in GIFT pre-processing, and we accounted for the
differences in EPI acquisition protocols among centers. The Infomax
approach was applied (Bell and Sejnowski, 1995) to estimate the inde-
pendent group components and 35 functional networks were considered
E. Premi et al. NeuroImage 189 (2019) 645–654(see Supplementary Fig. 1 for details). Subject-specific spatial patterns
and time-courses were derived using spatial-temporal regression and
then converted to Z-scores. The single time courses were detrended (to
remove baseline drifts from the scanners and/or physiological pulsa-
tions), orthogonalized with respect to 12-motion parameters, despiked
(replacement of outlier time points with 3rd order spline fitting to clean
neighbouring points) and filtered using a 5th order Butterworth filter
(0.01–0.15 Hz) (Abrol et al., 2016).
2.5. Windowed functional network connectivity and correlation patterns
decomposition (meta-states)
The dynamic functional network connectivity (dFNC) was achieved
using dynamic FNC toolbox implemented in GIFT (Damaraju et al.,
2014). dFNC was assessed using a sliding-window approach to esti-
mate correlation matrices between components for each segment.
Segments were defined with a tapered window convolving a rectangle
(width¼ 30, TRs¼ 66 s) with a Gaussian (σ¼ 3) and slide in steps of
1 TR. A LASSO approach with L1 regularization (100 repetitions) was
used to compute the covariance between the independent component
(IC) time-courses. To obtain the decomposition into connectivity pat-
terns (CPs), the spatial ICA (sICA) approach was applied, considering a
number of CPs of 6, in line with previous work on metastates in dy-
namic brain connectivity (5–6 CPs used) (Allen et al., 2014; Miller
et al., 2016). As previously described, the time-courses were dis-
cretized (to work over a more tractable space) into 8 bins (positive and
negative quartiles) and each timepoint was ended into a meta-state
(Miller et al., 2014). The time-courses for sICA CPs were derived
from the regression of each subject's dFNC information at each time
window on the group of sICA CPs. During dFNC preprocessing the
following covariates of no interest were considered: age, gender,
acquisition site, scanner type, family number, genetic status of the
proband, DVARS index (Power et al., 2012) and the variance associ-
ated with them has been regressed out from the windowed dynamic
functional network connectivity correlations for each subject at this
processing step. Furthermore, the potential confounding effect of
motion (DVARS index) across groups and the correlation with meta-
state measures were explored.
Four indexes of connectivity dynamism were considered: i) the
number of distinct meta-states the subjects occupied during their scans
(meta-state number); ii) the number of times that subjects switch from
one meta-state to another (meta-state changes), iii) the largest distance of
two meta-states that subjects occupied (meta-state span), and iv) the
overall distance travelled by each subject through the state space (the
sum of the L1 distances between successive meta-states, i.e. meta-state
total distance). Metastate indexes are global (not state specific) mea-
sures the describe the trajectory of the windowed correlations among the
different states. In meta-state framework, subject's state can be repre-
sented by varying degrees of multiple states, with lesser distortion in the
CPs, considering that contributions of all overlapping states were
recognized.
2.6. Statistical analysis
The assumption of normality for continuous variables was not satis-
fied for all group combinations, as assessed by Shapiro-Wilk's test
(p< 0.05). Thus, comparisons of demographic and clinical characteris-
tics between groups (mutation carriers vs. mutation non-carriers) were
assessed by Mann-Whitney U test for continuous variables and χ2 test for
categorical variables. Pearson's correlation was used to assess the rela-
tionship between the meta-state measures (meta-state number, meta-
state changes, meta-state span and meta-state total distance) and age at
expected symptom onset. Finally, partial correlation (considering age as
a nuisance variable) was used to test the relationship between meta-state
measures and cognitive/behavioural performances (CBI-R, MMSE, TMT-
A, TMT-B). All the statistical analysis was performed using IBM SPSS648Statistics 22.0 (Chicago, USA) and statistical significance level set at
p< 0.05, corrected for multiple comparisons (Benjamini-Hochberg False-
Discovery-Rate (FDR) correction (Benjamini and Hochberg, 1995)),
considering four meta-state measures and four clinical tests. Direct
comparisons (mutations carriers vs mutation non-carriers) and correla-
tion analyses (between age at expected symptom onset and meta-state
measures and between clinical tests and meta-states measures) were
carried out. Taking into account that preprocessing (Independent
Component Analysis, ICA) was performed using all subjects together and
it was not completely optimized for the subgroup analysis (requiring
separated preprocessing for each mutation group but making the evalu-
ation of the main effect hardly interpretable) we performed exploratory
analyses considering each gene (GRN, C9orf72 or MAPT) separately
versus mutation non carriers.
2.7. Data and code availability statement
The data used to support the findings of this study were derived from
the Genetic Frontotemporal Dementia Initiative (GENFI, http://genfi.
org.uk/). They are available on request from the Principal Investigator
of the GENFI consortium (Dr Jonathan Rohrer, University College Lon-
don, genfi@ucl.ac.uk).
3. Results
Two hundred-forty nine mutation carriers (82 with C9orf72, 122
with GRN and 45 with MAPT mutations) were considered, and
compared with 223 mutation non-carriers. Considering clinical and
demographic variables, mutation non-carriers were slightly older than
mutation carriers (47.2 13.2 vs 44.7 11.7, p¼ 0.042) (see Supple-
mentary Table 2 for details). We considered six connectivity patterns
(CPs) of dFNC, which are reported in Fig. 1. The colors of each CP
represent the direction and the strength of the correlation among the 35
considered network components (red: positive correlation and blue:
negative correlation).
dFNC was expressed as a weighted sum of the discretized six-
dimensional CPs, for each given point in time and for each subject.
Mutation carriers exhibited diminished dynamic fluidity, as they occu-
pied a fewer number of meta-states (i.e., meta-state numbers) and
changed from one meta-state to another less often (i.e., meta-state
changes) than mutation non-carriers (see Table 2). Furthermore, muta-
tion carriers operated over a restricted dynamic range with decreased
meta-state total distance, as they travelled less overall distance, between
successive meta-states, through the state space than mutation non-
carriers (see Table 2). We did not find any difference in meta-state
span between groups.
Taking into account the statistically significant difference of age be-
tween groups (mutation non-carriers were older then mutation carriers)
we also performed an exploratory analysis considering a subgroup of
non-carriers (n¼ 200) with a comparable age versus mutation carriers.
As reported in Supplementary Analysis 1, the results were similar to the
original groups, with a significantly altered meta-state dynamic con-
nectivity in mutation-carriers, supporting the idea that age at visit did not
explain meta-state differences.
The potential confounding effect of motion on meta-state measures
has been tested (see Supplementary Table 2 and Supplementary Table 3):
no significant differences in DVARS values among groups (C9orf72, GRN,
MAPT versus mutation-negative carriers) as well as no significant cor-
relations between DVARS values and meta-state measures were evident.
When other parameters of motion were considered no significant dif-
ferences between groups (also considering the three mutations sepa-
rately) were found. Furthermore, a weak (even if statistically significant)
correlation between motion parameters (i.e. FD) and meta-state mea-
sures was evident (see Supplementary Table 3). However, with a selec-
tion of subjects (either mutation carriers and non-carriers) with low-
movement (mean FD 0.2mm in line with literature data) (Parkes
Fig. 1. The six connectivity patterns (CPs) resulting from the dynamic Functional Network Connectivity (dFNC) analysis. The six correlations' matrix (among
the 35 considered network components) are reported. The colorbar represents the direction and the strength of each correlation (red: positive correlation, blue:
negative correlation).
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Table 2
Meta-state measures in the studied groups.
Variable Carriers
(n¼ 249)
Non-carriers
(n¼ 223)
pa
Number of distinct metastates,
mean SD
51.0 8.9 53.1 8.8 0.024
Number of meta-state changes,
mean SD
51.3 8.5 53.3 8.1 0.024
Meta-state span, mean SD 23.0 4.7 23.8 4.5 0.136
Meta-state total distance,
mean SD
82.1 17.5 86.2 17.3 0.027
a Mann-Whitney U test (carriers vs non-carriers) FDR-corrected for multiple
comparisons; SD: standard deviation.
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dexes (mutation-carriers versus mutation non-carriers) were demon-
strated (see Supplementary Analysis 2).
In Fig. 2, meta-state dynamics through time, meta-state numbers,
meta-state change points, and meta-state total distance in a representa-
tive mutation carrier and in a representative mutation non-carrier were
reported. Representative mutation non-carrier showed a greater brain
dynamism, as compared to a representative mutation carrier (panel A),
as suggested by the more complex pattern in the former subject, with an
higher number of realized meta-states (panel B), meta-state changes
(panel C), and greater travelled overall distance (panel D), compared to
the mutation carrier subject.
In the exploratory analysis (not corrected for multiple comparisons),
we evaluated C9orf72, GRN and MAPT mutation carriers separately, as
compared to HC. C9orf72 mutation carriers showed reduced meta-states
numbers (p¼ 0.032) and reduced meta-state changes (p¼ 0.041);MAPT
mutation carriers had reduced meta-states numbers (p¼ 0.042) and
reduced overall meta-state total distance (p¼ 0.046), while we did not
find significant findings in GRN mutation carriers, as compared to HC.
The correlation between meta-state measures and age at expected
onset in mutation carriers was then considered (FDR-corrected for mul-
tiple comparisons). The closer the age at expected symptom onset, the
lower the number of meta-states (Pearson's correlation, r¼0.174,
p¼ 0.012), the lower themeta-state changes (r¼0.166, p¼ 0.012), the
lower the meta-state span (r¼0.167, p¼ 0.012) and the lower the
meta-state total distance (r¼0.141, p¼ 0.027) was found. As explor-
atory analysis, we also tested the aforementioned correlation in the three
groups of mutations (see Supplementary Table 4) demonstrating that the
effect was mainly supported by C9orf72 mutation carriers.
Finally, the correlation between meta-state measures and cognitive
performance in mutation carriers and mutation non-carriers, considering
age at evaluation as a covariate, was assessed (not corrected for multiple
comparisons). TMT-A scores (the higher the scores the worse the per-
formances) were inversely correlated with meta-state span (r¼0.143,
p¼ 0.024) and meta-state total distance (r¼0.124, p¼ 0.050): inter-
estingly, exploring the correlation of TMT-A scores and meta-state
measures, the inverse correlation with meta-state span was primarily
related to C9orf72 group (r¼0.281, p¼ 0.011, not corrected for mul-
tiple comparisons). No other significant correlation between meta-state
measures and neuropsychological/behavioural tests in the three muta-
tions, separately, was demonstrated. No other significant correlations
between meta-state measures and MMSE, CBI-R or TMT-B were found.
4. Discussion
In this study, results showed consistent evidence of reduced global
flexibility and dynamism in the brain of presymptomatic FTD, which
progressively worse with proximity to age at expected symptoms onset.
Moreover, the impairment of global inner fluctuations of the brain was
well correlated with processing speed performances in asymptomatic
subjects carrying pathogenetic FTD mutations.
In the last decade, rs-fMRI has been used to estimate functional brain650connectivity, considering regions with temporally coherent brain ac-
tivity as “functional brain networks” (Buckner et al., 2009; Jafri et al.,
2008). Up to now, most studies have relied on two implicit assumptions:
the first is a “spatial assumption”, that each brain region participates in
exactly one network, and the second is a “temporal assumption”, that
the connectivity within each network are essentially static over time
(Allen et al., 2014; Ciric et al., 2017; Faghiri et al., 2018; Hutchison
et al., 2013). New evidence clearly suggests that the brain is dynami-
cally multistable, and spontaneous low-frequency fluctuations in BOLD
fMRI data during the acquisition capture reoccurring patterns (states) of
interactions among intrinsic networks at rest (chronnectome) (Calhoun
et al., 2014; Onton and Makeig, 2006). This is in line with spontaneous
activity fluctuations found in electrophysiological studies (Arieli et al.,
1996; Pascual-Marqui et al., 1995; Yanagawa and Mogi, 2009). This
“dynamic” inter-regional connections showed a high degree of repro-
ducibility (data analysis methods, grouping, decomposition techniques,
quality of the data, methodological validation with surrogate data
analysis) (Abrol et al., 2016, 2017). Such findings open a new chapter in
the study of neurodegenerative diseases, offering a different perspective
to investigate the earliest brain changes, thus considering global brain
connectivity instead of either single network connectivity or focal
neural damage.
In the present study, we assessed the chronnectome fingerprint in
preclinical monogenic FTD by considering meta-states. Meta-states
properly describe whole brain flexibility, moving from the concept that
each subject may be in a defined “state” of functional dynamic con-
nectivity in a given point in time to the concept that a subject may have
a weighted probability to be in more “states” in each given point in
time. Thus, in each subject, dynamic connectivity was represented by
the probability sum of the different connectivity patterns at a given
point in time. From this point of view, we explored those indexes (meta-
state numbers, changes, span, and total distance) related to the global
dynamic properties of the brain rather than specific states. This core
challenge allows us to better identify early and hidden features of brain
disorders, as already demonstrated in schizophrenia (Miller et al.,
2016).
Herein, we reported that asymptomatic mutation carriers a) passed
through a lower number of distinct meta-states (i.e., lower meta-state
number); b) less often switched between meta-states (i.e., lower meta-
state changes), and c) switched frequently between two meta-states at
close distal boundaries of the state space (i.e., lower mate-state total
distance), as compared to mutation non-carriers. Altogether, these find-
ings point to a precocious impairment of the inner fluctuations of the
brain with an effect on at-distance networks through a diminished dy-
namic fluidity (meta-state number and meta-state changes) and a
restricted dynamic range (meta-state total distance) in preclinical FTD
(Warren et al., 2013).
Prior work has primarily focused on topological differences among
networks in FTD, identifying structural and even functional changes of
specific brain networks in preclinical disease (Caroppo et al., 2015;
Dopper et al., 2014; Moreno et al., 2013; Pievani et al., 2014b; Premi
et al., 2014a, 2014b, 2016; Rohrer et al., 2015), evaluating neuropath-
ological progression according to the molecular nexopathy paradigm
(Warren et al., 2012). In the present work, we suggested that FTD at the
earliest disease stages affects whole brain efficiency, providing a com-
plementary view of presymptomatic FTD. From this point of view, the
potential perturbation of meta-state measures in the single mutation (as
supported by the exploratory analyses) should deserve attention with
separated dynamic connectivity analyses in each group.
Moreover, we reported that the greater the meta-state abnormalities
in mutation carriers, the closer the age at expected onset, in line with
the progressive changes which in turn lead to symptom onset and
structural damage in FTD. However, it should be noted that the degree
of correlation between meta-state perturbations and expected age at
onset was very low and statistically significant only in C9orf72 mutation
carriers. Finally, TMT-A, a test reflecting processing speed skills (Bowie
Fig. 2. Meta-state dynamics through time, meta-state numbers, meta-state change points, and meta-state total distance in a representative mutation carrier and in a
representative mutation non-carrier.
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range connectivity. This confirms and extends the previous hypothesis
of a strict link between chronnectome fingerprint and cognition per-
formances (Chen et al., 2016; Jia et al., 2014) that needs to be further
explored, also considering the strength of correlations in the
mutation-carriers group. The lack of correlation between cognitive/be-
havioural performances and meta-state measures might be addressed to
the weak abnormalities of cognition and behaviour in preclinical FTD
(Rohrer et al., 2015). Conversely, TMT-A, an index of preprocessing
speed skill, is one of the early cognitive marker in preclinical FTD
(Rohrer et al., 2015). The absence of a significant correlation between
TMT-A scores and meta-state measures in healthy controls further
supports the idea that this finding is not age-driven but mutation-driven.
Our study presents a number of limitations that need to be acknowl-
edged. First, the influence of vigilance (even though rs-fMRI data were
collected with closed eyes) was not evaluated (Wang et al., 2016).
Second, subject motion is of particular concern in dynamic analyses of
rs-fMRI (Wang et al., 2016). To overcome this limit, we included motion
parameters estimation as well as DVARS index (that describes the rate
of change of BOLD signal across the entire brain at each frame of the
data compared with the next one; in this sense, DVARS represents a
measure of how much the intensity of a brain image changes in com-
parison to the previous timepoint) in the preprocessing and in the sta-
tistical design, respectively (Abrol et al., 2016; Power et al., 2012).
Furthermore, also considering further indexes of absolute and relative
movement (i.e. framewise displacement, FD) we tested the relationship
between the aforementioned indexes and metastate measures as well as
with cognitive performances: as described in Supplementary Table 3 a
residual significant relationship between relative movement indexes (in
particular FD) was evident, supporting the hypothesis of a potential
influence of the movement, even after the multi-level correction.
However, to further corroborate our findings we performed an explor-
atory analysis (Supplementary Analysis 3) only considering a selection
of carriers and non-carriers with low-movement, with comparable
findings. Third, considering the unconstrained nature of the
resting-state signal, thought content during the scan represented a sig-
nificant source of variability, can only be partially evaluated by retro-
spective questionnaires (Marusak et al., 2017; O'Callaghan et al., 2015).
Four, scan time of acquisition was in line with (or even greater than)
previous studies (Allen et al., 2014; Marusak et al., 2017) even though
the development of effective dynamic functional connectivity statistical
approaches is still an open field, deserving attention in the future
(Hindriks et al., 2016; Miller et al., 2016; Shakil et al., 2016; Shine
et al., 2015; Yaesoubi et al., 2015). In line with this, the utilization of
nuisance covariates (in particular in multi-center studies) represents a
challenging issue, considering the different types of confounders
(continue or categorical variables) as well as the time-point to remove
the variance associated with them. As described in the Methods section
we performed nuisance variables regression during the windowed
functional network connectivity processing before metastate calcula-
tion, even if this was not completely standardized for dynamic con-
nectivity analysis and should be considered as limitation. Fifth, the
choice of the dimension of CPs decomposition (6 CPs), even if in line
with previous studies, is arbitrary: from this point of view, a data-driven
approach (elbow criterion of the cluster validity index as for state
measures calculation) (Marusak et al., 2017; Rashid et al., 2014, 2016)
should be implemented also for metastates analysis to increase the
overall standardization. To obtain the decomposition into connectivity
patterns (CPs), the spatial ICA (sICA) approach was applied, considering
a number of CPs of 6, in line with previous work on metastates in dy-
namic brain connectivity (5–6 CPs used).
Despite these limitations, to the best of our knowledge, this is the first
study applying chronnectome approach to neurodegenerative dementias.
The exploration of time-varying aspects of functional connectivity un-
veiled aspects of the underappreciated early brain changes in FTD: beside
the well-established concept of the selective vulnerability of specific652brain regions (molecular nexopathy paradigm) in FTD (Warren et al.,
2013), the present findings supported the view that at the very early
disease stage FTD is affecting brain as global system as well. These
findings may have important implication on clinical grounds, as tracking
desynchronization of the inner fluctuations of the brain might be a
helpful prognostic marker to be used in future pharmacological and
prevention trials and it could be considered a feasible approach to
identify novel targets of intervention.
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Meta-state dynamics through time (panel A), meta-state numbers
(panel B), meta-state change points (panel C), and meta-state total dis-
tance (panel D) in a representative mutation non carrier (left column)
and representative mutation carrier (right column).
The colorbar represents the strength of probability to be in each meta-
state. X-axis: the six connectivity patterns (Cps) are reported, from 1 to 6;
Y-axis: time (seconds, after time course discretization in quartiles).
References
Abrol, A., Chaze, C., Damaraju, E., Calhoun, V.D., 2016. The chronnectome: evaluating
replicability of dynamic connectivity patterns in 7500 resting fMRI datasets. Conf
Proc IEEE Eng Med Biol Soc 5571–5574, 2016.
Abrol, A., Damaraju, E., Miller, R.L., SDtephen, J.M., Claus, E.D., Mayer, A.R.,
Calhoun, V.D., 2017. Replicability of time-varying connectivity patterns in large
resting state fMRI samples. Neuroimage 163, 160–176.
Allen, E.A., Damaraju, E., Plis, S.M., Erhardt, E.B., Eichele, T., Calhoun, V.D., 2014.
Tracking whole-brain connectivity dynamics in the resting state. Cerebr. Cortex 24,
663–676.
Arieli, A., Sterkin, A., Grinvald, A., Aertsen, A., 1996. Dynamics of ongoing activity:
explanation of the large variability in evoked cortical responses. Science 273,
1868–1871.
Avena-Koenigsberger, A., Misic, B., Sporns, O., 2017. Communication dynamics in
complex brain networks. Nat. Rev. Neurosci. 19, 17–33.
Bell, A.J., Sejnowski, T.J., 1995. An information-maximization approach to blind
separation and blind deconvolution. Neural Comput. 7, 1129–1159.
Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J. Roy. Stat. Soc. B 57 1, 289–300.
Borroni, B., Alberici, A., Premi, E., Archetti, S., Garibotto, V., Agosti, C., Gasparotti, R., Di
Luca, M., Perani, D., Padovani, A., 2008a. Brain magnetic resonance imaging
structural changes in a pedigree of asymptomatic progranulin mutation carriers.
Rejuvenation Res. 11, 585–595.
Borroni, B., Archetti, S., Alberici, A., Agosti, C., Gennarelli, M., Bigni, B., Bonvicini, C.,
Ferrari, M., Bellelli, G., Galimberti, D., Scarpini, E., Di Lorenzo, D., Caimi, L.,
Caltagirone, C., Di Luca, M., Padovani, A., 2008b. Progranulin genetic variations in
frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian
clinical series. Neurogenetics 9, 197–205.
Bowie, C.R., Harvey, P.D., 2006. Administration and interpretation of the trail making
test. Nat. Protoc. 1, 2277–2281.
Buckner, R.L., Sepulcre, J., Talukdar, T., Krienen, F.M., Liu, H., Hedden, T., Andrews-
Hanna, J.R., Sperling, R.A., Johnson, K.A., 2009. Cortical hubs revealed by intrinsic
functional connectivity: mapping, assessment of stability, and relation to Alzheimer's
disease. J. Neurosci. 29, 1860–1873.
Calhoun, V.D., Adali, T., Pearlson, G.D., Pekar, J.J., 2001. A method for making group
inferences from functional MRI data using independent component analysis. Hum.
Brain Mapp. 14, 140–151.
Calhoun, V.D., Miller, R., Pearlson, G., Adali, T., 2014. The chronnectome: time-varying
connectivity networks as the next frontier in fMRI data discovery. Neuron 84,
262–274.
Calhoun, V.D., Wager, T.D., Krishnan, A., Rosch, K.S., Seymour, K.E., Nebel, M.B.,
Mostofsky, S.H., Nyalakanai, P., Kiehl, K., 2017. The impact of T1 versus EPI spatial
normalization templates for fMRI data analyses. Hum. Brain Mapp. 38, 5331–5342.
Canolty, R.T., Ganguly, K., Kennerley, S.W., Cadieu, C.F., Koepsell, K., Wallis, J.D.,
Carmena, J.M., 2010. Oscillatory phase coupling coordinates anatomically dispersed
functional cell assemblies. Proc. Natl. Acad. Sci. U. S. A. 107, 17356–17361.
Caroppo, P., Habert, M.O., Durrleman, S., Funkiewiez, A., Perlbarg, V., Hahn, V.,
Bertin, H., Gaubert, M., Routier, A., Hannequin, D., Deramecourt, V., Pasquier, F.,
Rivaud-Pechoux, S., Vercelletto, M., Edouart, G., Valabregue, R., Lejeune, P.,
E. Premi et al. NeuroImage 189 (2019) 645–654Didic, M., Corvol, J.C., Benali, H., Lehericy, S., Dubois, B., Colliot, O., Brice, A., Le
Ber, I., 2015. Lateral temporal lobe: an early imaging marker of the presymptomatic
GRN disease? J Alzheimers Dis 47, 751–759.
Chang, C., Glover, G.H., 2010. Time-frequency dynamics of resting-state brain
connectivity measured with fMRI. Neuroimage 50, 81–98.
Chen, T., Cai, W., Ryali, S., Supekar, K., Menon, V., 2016. Distinct global brain dynamics
and spatiotemporal organization of the salience network. PLoS Biol. 14 e1002469.
Ciric, R., Nomi, J.S., Uddin, L.Q., Satpute, A.B., 2017. Contextual connectivity: a
framework for understanding the intrinsic dynamic architecture of large-scale
functional brain networks. Sci. Rep. 7, 6537.
Damaraju, E., Allen, E.A., Belger, A., Ford, J.M., McEwen, S., Mathalon, D.H.,
Mueller, B.A., Pearlson, G.D., Potkin, S.G., Preda, A., Turner, J.A., Vaidya, J.G., van
Erp, T.G., Calhoun, V.D., 2014. Dynamic functional connectivity analysis reveals
transient states of dysconnectivity in schizophrenia. Neuroimage Clin 5, 298–308.
Damoiseaux, J.S., Rombouts, S.A., Barkhof, F., Scheltens, P., Stam, C.J., Smith, S.M.,
Beckmann, C.F., 2006. Consistent resting-state networks across healthy subjects.
Proc. Natl. Acad. Sci. U. S. A. 103, 13848–13853.
De Luca, M., Beckmann, C.F., De Stefano, N., Matthews, P.M., Smith, S.M., 2006. fMRI
resting state networks define distinct modes of long-distance interactions in the
human brain. Neuroimage 29, 1359–1367.
de Pasquale, F., Corbetta, M., Betti, V., Della Penna, S., 2018 Oct 15. Cortical cores in
network dynamics. Neuroimage 180 (Pt B), 370–382.
Dopper, E.G., Rombouts, S.A., Jiskoot, L.C., den Heijer, T., de Graaf, J.R., de Koning, I.,
Hammerschlag, A.R., Seelaar, H., Seeley, W.W., Veer, I.M., van Buchem, M.A.,
Rizzu, P., van Swieten, J.C., 2014. Structural and functional brain connectivity in
presymptomatic familial frontotemporal dementia. Neurology 83, e19–26.
Du, Y., Allen, E.A., He, H., Sui, J., Wu, L., Calhoun, V.D., 2016. Artifact removal in the
context of group ICA: a comparison of single-subject and group approaches. Hum.
Brain Mapp. 37, 1005–1025.
Faghiri, A., SDtephen, J.M., Wang, Y.P., Wilson, T.W., 2018. Changing brain connectivity
dynamics: from early childhood to adulthood, 39, 1108–1117.
Fries, P., 2005. A mechanism for cognitive dynamics: neuronal communication through
neuronal coherence. Trends Cognit. Sci. 9, 474–480.
Gorno-Tempini, M.L., Hillis, A.E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S.F.,
Ogar, J.M., Rohrer, J.D., Black, S., Boeve, B.F., Manes, F., Dronkers, N.F.,
Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B.L., Knopman, D.S.,
Hodges, J.R., Mesulam, M.M., Grossman, M., 2011. Classification of primary
progressive aphasia and its variants. Neurology 76, 1006–1014.
Hillebrand, A., Tewarie, P., van Dellen, E., Yu, M., Carbo, E.W., Douw, L., Gouw, A.A., van
Straaten, E.C., Stam, C.J., 2016. Direction of information flow in large-scale resting-
state networks is frequency-dependent. Proc. Natl. Acad. Sci. U. S. A. 113,
3867–3872.
Hindriks, R., Adhikari, M.H., Murayama, Y., Ganzetti, M., Mantini, D., Logothetis, N.K.,
Deco, G., 2016. Can sliding-window correlations reveal dynamic functional
connectivity in resting-state fMRI? Neuroimage 127, 242–256.
Hutchison, R.M., Womelsdorf, T., Gati, J.S., Everling, S., Menon, R.S., 2013. Resting-state
networks show dynamic functional connectivity in awake humans and anesthetized
macaques. Hum. Brain Mapp. 34, 2154–2177.
Jafri, M.J., Pearlson, G.D., Stevens, M., Calhoun, V.D., 2008. A method for functional
network connectivity among spatially independent resting-state components in
schizophrenia. Neuroimage 39, 1666–1681.
Jenkinson, M., Beckmann, C.F., Behrens, T.E., Woolrich, M.W., Smith, S.M., 2012. FSL.
Neuroimage 62, 782–790.
Jia, H., Hu, X., Deshpande, G., 2014. Behavioral relevance of the dynamics of the
functional brain connectome. Brain Connect. 4, 741–759.
Lee, S.E., Sias, A.C., Mandelli, M.L., Brown, J.A., Brown, A.B., Khazenzon, A.M.,
Vidovszky, A.A., Zanto, T.P., Karydas, A.M., Pribadi, M., Dokuru, D., Coppola, G.,
Geschwind, D.H., Rademakers, R., Gorno-Tempini, M.L., Rosen, H.J., Miller, B.L.,
Seeley, W.W., 2017. Network degeneration and dysfunction in presymptomatic
C9ORF72 expansion carriers. Neuroimage Clin 14, 286–297.
Liu, J., Liao, X., Xia, M., He, Y., 2018. Chronnectome Fingerprinting: Identifying
Individuals and Predicting Higher Cognitive Functions Using Dynamic Brain
Connectivity Patterns, vol. 39, pp. 902–915.
Marusak, H.A., Calhoun, V.D., Brown, S., Crespo, L.M., Sala-Hamrick, K., Gotlib, I.H.,
Thomason, M.E., 2017. Dynamic functional connectivity of neurocognitive networks
in children. Hum. Brain Mapp. 38, 97–108.
Mikl, M., Marecek, R., Hlustik, P., Pavlicova, M., Drastich, A., Chlebus, P., Brazdil, M.,
Krupa, P., 2008. Effects of spatial smoothing on fMRI group inferences. Magn. Reson.
Imaging 26, 490–503.
Miller, R.L., Yaesoubi, M., Calhoun, V.D., 2014. Higher dimensional analysis shows
reduced dynamism of time-varying network connectivity in schizophrenia patients.
Conf Proc IEEE Eng Med Biol Soc 3837–3840, 2014.
Miller, R.L., Yaesoubi, M., Turner, J.A., Mathalon, D., Preda, A., Pearlson, G., Adali, T.,
Calhoun, V.D., 2016. Higher dimensional meta-state analysis reveals reduced resting
fMRI connectivity dynamism in schizophrenia patients. PLoS One 11 e0149849.
Moreno, F., Sala-Llonch, R., Barandiaran, M., Sanchez-Valle, R., Estanga, A., Bartres-
Faz, D., Sistiaga, A., Alzualde, A., Fernandez, E., Marti Masso, J.F., Lopez de
Munain, A., Indakoetxea, B., 2013. Distinctive age-related temporal cortical thinning
in asymptomatic granulin gene mutation carriers. Neurobiol. Aging 34, 1462–1468.
Morris, J.C., Weintraub, S., Chui, H.C., Cummings, J., Decarli, C., Ferris, S., Foster, N.L.,
Galasko, D., Graff-Radford, N., Peskind, E.R., Beekly, D., Ramos, E.M., Kukull, W.A.,
2006. The Uniform data set (UDS): clinical and cognitive variables and descriptive
data from alzheimer disease centers. Alzheimers Dis. Assoc. Disord. 20, 210–216.
O'Callaghan, C., Shine, J.M., Lewis, S.J., Andrews-Hanna, J.R., Irish, M., 2015. Shaped by
our thoughts-a new task to assess spontaneous cognition and its associated neural
correlates in the default network. Brain Cogn. 93, 1–10.653Onton, J., Makeig, S., 2006. Information-based modeling of event-related brain dynamics.
Prog. Brain Res. 159, 99–120.
Parkes, L., Fulcher, B., Yucel, M., Fornito, A., 2018. An evaluation of the efficacy,
reliability, and sensitivity of motion correction strategies for resting-state functional
MRI. Neuroimage 171, 415–436.
Pascual-Marqui, R.D., Michel, C.M., Lehmann, D., 1995. Segmentation of brain electrical
activity into microstates: model estimation and validation. IEEE Trans. Biomed. Eng.
42, 658–665.
Pievani, M., Filippini, N., van den Heuvel, M.P., Cappa, S.F., Frisoni, G.B., 2014a. Brain
connectivity in neurodegenerative diseases-from phenotype to proteinopathy. Nat.
Rev. Neurol. 10, 620–633.
Pievani, M., Paternico, D., Benussi, L., Binetti, G., Orlandini, A., Cobelli, M., Magnaldi, S.,
Ghidoni, R., Frisoni, G.B., 2014b. Pattern of structural and functional brain
abnormalities in asymptomatic granulin mutation carriers. Alzheimers Dement 10,
S354–S363 e351.
Power, J.D., Barnes, K.A., Snyder, A.Z., Schlaggar, B.L., Petersen, S.E., 2012. Spurious but
systematic correlations in functional connectivity MRI networks arise from subject
motion. Neuroimage 59, 2142–2154.
Premi, E., Cauda, F., Costa, T., Diano, M., Gazzina, S., Gualeni, V., Alberici, A.,
Archetti, S., Magoni, M., Gasparotti, R., Padovani, A., Borroni, B., 2016. Looking for
neuroimaging markers in frontotemporal lobar degeneration clinical trials: a multi-
voxel pattern analysis study in granulin disease. J Alzheimers Dis 51, 249–262.
Premi, E., Cauda, F., Gasparotti, R., Diano, M., Archetti, S., Padovani, A., Borroni, B.,
2014a. Multimodal FMRI resting-state functional connectivity in granulin mutations:
the case of fronto-parietal dementia. PLoS One 9 e106500.
Premi, E., Formenti, A., Gazzina, S., Archetti, S., Gasparotti, R., Padovani, A., Borroni, B.,
2014b. Effect of TMEM106B polymorphism on functional network connectivity in
asymptomatic GRN mutation carriers. JAMA Neurol 71, 216–221.
Premi, E., Grassi, M., van Swieten, J., Galimberti, D., Graff, C., Masellis, M., Tartaglia, C.,
Tagliavini, F., Rowe, J.B., Laforce Jr., R., Finger, E., Frisoni, G.B., de Mendonca, A.,
Sorbi, S., Gazzina, S., Cosseddu, M., Archetti, S., Gasparotti, R., Manes, M.,
Alberici, A., Cardoso, M.J., Bocchetta, M., Cash, D.M., Ourselin, S., Padovani, A.,
Rohrer, J.D., Borroni, B., 2017. Cognitive reserve and TMEM106B genotype
modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.
Brain 140, 1784–1791.
Preti, M.G., Bolton, T.A., Van De Ville, D., 2017. The dynamic functional connectome:
state-of-the-art and perspectives. Neuroimage 160, 41–54.
Rascovsky, K., Hodges, J.R., Knopman, D., Mendez, M.F., Kramer, J.H., Neuhaus, J., van
Swieten, J.C., Seelaar, H., Dopper, E.G., Onyike, C.U., Hillis, A.E., Josephs, K.A.,
Boeve, B.F., Kertesz, A., Seeley, W.W., Rankin, K.P., Johnson, J.K., Gorno-
Tempini, M.L., Rosen, H., Prioleau-Latham, C.E., Lee, A., Kipps, C.M., Lillo, P.,
Piguet, O., Rohrer, J.D., Rossor, M.N., Warren, J.D., Fox, N.C., Galasko, D.,
Salmon, D.P., Black, S.E., Mesulam, M., Weintraub, S., Dickerson, B.C., Diehl-
Schmid, J., Pasquier, F., Deramecourt, V., Lebert, F., Pijnenburg, Y., Chow, T.W.,
Manes, F., Grafman, J., Cappa, S.F., Freedman, M., Grossman, M., Miller, B.L., 2011.
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal
dementia. Brain 134, 2456–2477.
Rashid, B., Arbabshirani, M.R., Damaraju, E., Cetin, M.S., Miller, R., Pearlson, G.D.,
Calhoun, V.D., 2016. Classification of schizophrenia and bipolar patients using static
and dynamic resting-state fMRI brain connectivity. Proc. Natl. Acad. Sci. U. S. A. 134,
645–657.
Rashid, B., Damaraju, E., Pearlson, G.D., Calhoun, V.D., 2014. Dynamic connectivity
states estimated from resting fMRI Identify differences among Schizophrenia, bipolar
disorder, and healthy control subjects. Front. Hum. Neurosci. 8, 897.
Rohrer, J.D., Nicholas, J.M., Cash, D.M., van Swieten, J., Dopper, E., Jiskoot, L., van
Minkelen, R., Rombouts, S.A., Cardoso, M.J., Clegg, S., Espak, M., Mead, S.,
Thomas, D.L., De Vita, E., Masellis, M., Black, S.E., Freedman, M., Keren, R.,
MacIntosh, B.J., Rogaeva, E., Tang-Wai, D., Tartaglia, M.C., Laforce Jr., R.,
Tagliavini, F., Tiraboschi, P., Redaelli, V., Prioni, S., Grisoli, M., Borroni, B.,
Padovani, A., Galimberti, D., Scarpini, E., Arighi, A., Fumagalli, G., Rowe, J.B., Coyle-
Gilchrist, I., Graff, C., Fallstrom, M., Jelic, V., Stahlbom, A.K., Andersson, C.,
Thonberg, H., Lilius, L., Frisoni, G.B., Pievani, M., Bocchetta, M., Benussi, L.,
Ghidoni, R., Finger, E., Sorbi, S., Nacmias, B., Lombardi, G., Polito, C., Warren, J.D.,
Ourselin, S., Fox, N.C., Rossor, M.N., Binetti, G., 2015. Presymptomatic cognitive and
neuroanatomical changes in genetic frontotemporal dementia in the Genetic
Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet
Neurol. 14, 253–262.
Sakoglu, U., Pearlson, G.D., Kiehl, K.A., Wang, Y.M., Michael, A.M., Calhoun, V.D., 2010.
A method for evaluating dynamic functional network connectivity and task-
modulation: application to schizophrenia. Magma 23, 351–366.
Shakil, S., Lee, C.H., Keilholz, S.D., 2016. Evaluation of sliding window correlation
performance for characterizing dynamic functional connectivity and brain states.
Neuroimage 133, 111–128.
Shine, J.M., Koyejo, O., Bell, P.T., Gorgolewski, K.J., Gilat, M., Poldrack, R.A., 2015.
Estimation of dynamic functional connectivity using Multiplication of Temporal
Derivatives. Neuroimage 122, 399–407.
Van Dijk, K.R., Sabuncu, M.R., Buckner, R.L., 2012. The influence of head motion on
intrinsic functional connectivity MRI. Neuroimage 59, 431–438.
Wang, C., Ong, J.L., Patanaik, A., Zhou, J., 2016. Spontaneous Eyelid Closures Link
Vigilance Fluctuation with fMRI Dynamic Connectivity States, vol. 113,
pp. 9653–9658.
Warren, J.D., Rohrer, J.D., Hardy, J., 2012. Disintegrating brain networks: from
syndromes to molecular nexopathies. Neuron 73, 1060–1062.
Warren, J.D., Rohrer, J.D., Schott, J.M., Fox, N.C., Hardy, J., Rossor, M.N., 2013.
Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends
Neurosci. 36, 561–569.
E. Premi et al. NeuroImage 189 (2019) 645–654Wear, H.J., Wedderburn, C.J., Mioshi, E., Williams-Gray, C.H., Mason, S.L., Barker, R.A.,
Hodges, J.R., 2008. The Cambridge behavioural inventory revised. Dement
Neuropsychol 2, 102–107.
Whitwell, J.L., Jack Jr., C.R., Boeve, B.F., Senjem, M.L., Baker, M., Rademakers, R.,
Ivnik, R.J., Knopman, D.S., Wszolek, Z.K., Petersen, R.C., Josephs, K.A., 2009. Voxel-
based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN.
Neurology 72, 813–820.
Whitwell, J.L., Josephs, K.A., Avula, R., Tosakulwong, N., Weigand, S.D., Senjem, M.L.,
Vemuri, P., Jones, D.T., Gunter, J.L., Baker, M., Wszolek, Z.K., Knopman, D.S.,
Rademakers, R., Petersen, R.C., Boeve, B.F., Jack Jr., C.R., 2011. Altered functional
connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology 77,
866–874.654Yaesoubi, M., Allen, E.A., Miller, R.L., Calhoun, V.D., 2015. Dynamic coherence analysis
of resting fMRI data to jointly capture state-based phase, frequency, and time-domain
information. Neuroimage 120, 133–142.
Yan, C.G., Wang, X.D., Zuo, X.N., Zang, Y.F., 2016. DPABI: data processing & analysis for
(Resting-State) brain imaging. Neuroinformatics 14, 339–351.
Yanagawa, T., Mogi, K., 2009. Analysis of ongoing dynamics in neural networks.
Neurosci. Res. 64, 177–184.
Zhou, J., Greicius, M.D., Gennatas, E.D., Growdon, M.E., Jang, J.Y., Rabinovici, G.D.,
Kramer, J.H., Weiner, M., Miller, B.L., Seeley, W.W., 2010. Divergent network
connectivity changes in behavioural variant frontotemporal dementia and
Alzheimer's disease. Brain 133, 1352–1367.
